Acta Medica Scandinavica

Cover image for Acta Medica Scandinavica

January/December 1981

Volume 210, Issue S652

Pages 7–189

Currently known as: Journal of Internal Medicine

  1. Introduction

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. You have free access to this content
      INTRODUCTION (page 7)

      Thor-Björn Conradson

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06780.x

  2. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. PATHOPHYSIOLOGY (pages 9–11)

      Lars Werkö

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06781.x

    2. EPIDEMIOLOGY (pages 13–17)

      J. Anders Vedin, Claes Wilhelmsson, Henry Eriksson and Kurt Svärdsudd

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06782.x

  3. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (pages 18–20)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06783.x

  4. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. CLINICAL DIAGNOSTICS (pages 21–26)

      Bengt W. Johansson

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06784.x

  5. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (page 27)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06785.x

  6. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. RADIOLOGICAL DIAGNOSIS (pages 29–32)

      Ulf Tylén

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06786.x

  7. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (pages 32–33)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06787.x

  8. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. NON-INVASIVE METHODS FOR ASSESSING CARDIAC PERFORMANCE IN CHF (pages 35–47)

      John Wikstrand and Ingemar Wallentin

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06788.x

  9. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (page 48)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06789.x

  10. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. RADIONUCLIDE EVALUATION OF CHF (pages 49–55)

      Jan Lessem

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06790.x

  11. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (pages 55–56)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06791.x

  12. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. INVASIVE DIAGNOSTICS (pages 57–62)

      Bo Liander

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06792.x

  13. General Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. GENERAL DISCUSSION (pages 63–67)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06793.x

  14. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. PHARMACOLOGICAL ASPECTS ON THE TREATMENT OF CHF (pages 69–90)

      Karl-Erik Andersson

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06794.x

  15. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (pages 90–91)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06795.x

  16. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. HYDRALAZINE IN CHRONIC CHF (pages 99–113)

      Kanu Chatterjee, Jean-Lucien Rouleau and Barry M. Massie

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06797.x

    2. MANAGEMENT OF REFRACTORY CHF WITH PRAZOSIN: IMPORTANCE OF TOLERANCE AND TACHYPHYLAXIS (pages 115–124)

      Najam A. Awan, Mark K. Evenson, Kathleen E. Needham and Dean T. Mason

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06798.x

    3. NITROPRUSSIDE INFUSION IN ACUTE MYOCARDIAL INFARCTION (pages 125–127)

      Jay N. Cohn, Joseph A. Franciosa and Gary S. Francis

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06799.x

  17. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (page 127)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06800.x

  18. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. PHENTOLAMINE IN ACUTE MYOCARDIAL INFARCTION: HEMODYNAMIC AND METABOLIC EFFECTS (pages 129–134)

      Kanu Chatterjee and William W. Parmley

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06801.x

  19. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (page 134)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06802.x

  20. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. INFLUENCE OF NITROGLYCERIN ON CENTRAL HAEMODYNAMICS AND VA/QC OF THE LUNGS IN THE POSTOPERATIVE PERIOD AFTER CORONARY BYPASS SURGERY (pages 135–143)

      Alf Holmgren, Elisabet Anjou, Lisbet Broman and Staffan Lundberg

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06803.x

    2. HAEMODYNAMIC EFFECTS OF PRAZOSIN IN CHF (pages 145–148)

      Stuart R. Reuben, Peilang Kuan, Elsie V. Gale and Pamela M. Wilde

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06804.x

    3. LOSS OF PRAZOSIN EFFECT IN SEVERE CHRONIC CHF (pages 149–152)

      Halfdan Ihlen, Erik Thaulow, John Kjekshus and Kolbjörn Forfang

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06805.x

  21. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (pages 152–154)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06806.x

  22. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. MANAGEMENT OF SEVERE CHRONIC CHF WITH ORAL PIRBUTEROL (pages 155–161)

      Najam A. Awan, Kathleen Needham, Mark K. Evenson and Dean T. Mason

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06807.x

  23. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (page 162)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06808.x

  24. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. COMPARISON OF THE VASODILATOR PRAZOSIN AND THE SELECTIVE BETA1 AGONIST PRENALTEROL ON REST AND EXERCISE HAEMODYNAMICS IN CHF (pages 163–168)

      Ian Hutton, Ann C. Tweddel, Bruce C. Bastian and R. Gordon Murray

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06809.x

  25. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (page 168)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06810.x

  26. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. BENEFICIAL EFFECTS OF PROSTAGLANDIN E1 ON MYOCARDIAL ENERGETICS AND PUMP PERFORMANCE IN SEVERE CHF (pages 169–171)

      Najam A. Awan, Kathleen E. Needham, Mark K. Evenson, John Hermanovich, Marc Gradman and Dean T. Mason

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06811.x

  27. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (pages 171–172)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06812.x

  28. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. SUSTAINED EFFECT OF HYDRALAZINE IN LONG TERM TREATMENT OF CHF (pages 173–176)

      Thor-Björn Conradson and Lars Rydén

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06813.x

  29. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (page 176)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06814.x

  30. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
  31. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (page 180)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06816.x

  32. Original Article

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. CAPTOPRIL - AN ORAL ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN CHF (pages 181–187)

      Kanu Chatterjee, Jean-Lucien Rouleau and William W. Parmley

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06817.x

  33. Discussion

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. DISCUSSION (page 187)

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06818.x

  34. Closing Remarks

    1. Top of page
    2. Introduction
    3. Original Article
    4. Discussion
    5. Original Article
    6. Discussion
    7. Original Article
    8. Discussion
    9. Original Article
    10. Discussion
    11. Original Article
    12. Discussion
    13. Original Article
    14. General Discussion
    15. Original Article
    16. Discussion
    17. Original Article
    18. Discussion
    19. Original Article
    20. Discussion
    21. Original Article
    22. Discussion
    23. Original Article
    24. Discussion
    25. Original Article
    26. Discussion
    27. Original Article
    28. Discussion
    29. Original Article
    30. Discussion
    31. Original Article
    32. Discussion
    33. Original Article
    34. Discussion
    35. Closing Remarks
    1. CLOSING REMARKS (page 189)

      Lars Rydén

      Version of Record online: 24 APR 2009 | DOI: 10.1111/j.0954-6820.1981.tb06819.x

SEARCH

SEARCH BY CITATION